Pathophysiologically relevant conditions will be situations of low integrin–collagen interaction (including low integrin expression), altered PTPN11 activity such as in Noonan syndrome patients, and partial interference in platelet GPVI activity. This evidence concerns the gene GP6 and Noonan syndrome.